Selected Publications
Qarni TN, Jones FJS, Drachman B, Khella S, Pieretti J, Bustamante NS, Karam C.: Treatment characteristics of patients with hereditary transthyretin amyloidosis: a cohort study Orphanet J Rare Dis. : 2024 .
Jones FJS, Singer M, Zager E, Karam C.: Mononeuropathy Due to Inflammatory Pseudotumor of Nerve Neurology. : 2024.
Pottinger TD, Motelow JE, Povysil G, Moreno CAM, Ren Z, Phatnani H; New York Genome Center ALS Sequencing Consortium; Aitman TJ, Santoyo-Lopez J; Scottish Genomes Partnership; Mitsumoto H; ALS COSMOS Study Group; PLS COSMOS Study Group; GTAC Investigators; Goldstein DB, Harms MB. Rare: Rare variant analyses validate known ALS genes in a multi-ethnic population and identifies ANTXR2 as a candidate in PLS.
BMC Genomics. : 2024.
Traub R, Qarni T, Cohen AD, Karam C.: Paraproteinemic neuropathies Muscle Nerve. : 2024.
Berends M, Nienhuis HLA, Adams D, Karam C, Luigetti M, Polydefkis M, Reilly MM, Sekijima Y, Hazenberg BPC.: Neurofilament Light Chains in Systemic Amyloidosis: A Systematic Review Int J Mol Sci. : 2024.
Howard JF Jr, Bril V, Vu T, Karam C, Peric S, De Bleecker JL, Murai H, Meisel A, Beydoun SR, Pasnoor M, Guglietta A, Van Hoorick B, Steeland S, T'joen C, Utsugisawa K, Verschuuren J, Mantegazza R; ADAPT+ Study Group.: Long-term safety, tolerability, and efficacy of efgartigimod (ADAPT+): interim results from a phase 3 open-label extension study in participants with generalized myasthenia gravis Front. Neurol. : 2024.
Karam C, Mauermann ML, Gonzalez-Duarte A, Kaku MC, Ajroud-Driss S, Brannagan TH 3rd, Polydefkis M.: Diagnosis and treatment of hereditary transthyretin amyloidosis with polyneuropathy in the United States: Recommendations from a panel of experts Muscle Nerve : 2024.
Singer M, Khella S, Bird S, McIntosh P, Paudyal B, Wadhwani A, Quinn C, Karam C.: Single institution experience with efgartigimod in patients with myasthenia gravis: Patient selection, dosing schedules, treatment response, and adverse events Muscle Nerve. : 2023.
Bril V, Howard JF Jr, Karam C, De Bleecker JL, Murai H, Utsugisawa K, Ulrichts P, Brauer E, Zhao S, Mantegazza R, Vu T; ADAPT Study Group.: Effect of efgartigimod on muscle group subdomains in participants with generalized myasthenia gravis: post hoc analyses of the phase 3 pivotal ADAPT study Eur J Neurol. : 2023.
Morganroth J, Ljungberg L, Goldstein A, Kallish S, Asher SB, Quinn C, Price RS, Karam C.: Adult-Onset Thymidine Kinase Gene (TK2) Deficiency Neurology. : 2023.
View all publications
Academic Contact Information
3400 Spruce St., 3 West Gates
Philadelphia,
PA
19104
Phone: 215-615-3751
Patient appointments: 800-789-7366